British drugmaker AstraZeneca Plc said on Thursday its vaccine was 76% effective in preventing symptomatic COVID-19 and that it has submitted the results to the US Data and Safety Monitoring Board.
AstraZeneca COVID-19 vaccine 76% effective in updated US trial results
